The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
AKT plays a central role in tumorigenesis
Testa, J. R., & Bellacosa, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211430998 · Cited by 944
Beta-caryophyllene is a dietary cannabinoid.
Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803601105 · Cited by 906
The Akt-mTOR tango and its relevance to cancer
Hay, N. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.008 · Cited by 821
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Madrid, L. V., Mayo, M. W., Reuther, J. Y., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101103200 · Cited by 777
Redox signaling and the MAP kinase pathways
Torres, M., & Forman, H. J. (2003) · BioFactors · doi:10.1002/biof.5520170128 · Cited by 580
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Boutros, T., Chevet, E., & Metrakos, P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00106 · Cited by 545
The modular phosphorylation and activation of p70s6k
Pullen, N., & Thomas, G. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00323-2 · Cited by 540
Lee, J. Y., Ye, J., Gao, Z., Youn, H. S., Lee, W. H., Zhao, L., Sizemore, N., & Hwang, D. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305213200 · Cited by 524
Sesquiterpenes from Clove (Eugenia caryophyllata) as Potential Anticarcinogenic Agents
Zheng, G.-Q., Kenney, P. M., & Lam, L. K. T. (1992) · Journal of Natural Products · doi:10.1021/np50085a029 · Cited by 346
Screening for Antiviral Activities of Isolated Compounds from Essential Oils
Astani, A., Reichling, J., & Schnitzler, P. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nep187 · Cited by 336
Wink, M. (2008) · Current Drug Metabolism · doi:10.2174/138920008786927794 · Cited by 314
Stress-Responsive Protein Kinases in Redox-Regulated Apoptosis Signaling
Matsuzawa, A., & Ichijo, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.472 · Cited by 282
Martin, G. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00216-2 · Cited by 281
Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
Gao, N., Zhang, Z., Jiang, B.-H., & Shi, X. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.132 · Cited by 275
Murillo, H. (2001) · Endocrinology · doi:10.1210/en.142.11.4795 · Cited by 263
Survivin mediates resistance to antiandrogen therapy in prostate cancer
Zhang, M., Latham, D. E., Delaney, M. A., & Chakravarti, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208490 · Cited by 223
Xiao, D., Powolny, A. A., Moura, M. B., Kelley, E. E., Bommareddy, A., Kim, S.-H., Hahm, E.-R., Normolle, D., Van Houten, B., & Singh, S. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063255 · Cited by 176
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
Castaneda, C. A., Cortes-Funes, H., Gomez, H. L., & Ciruelos, E. M. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9261-0 · Cited by 173
Xiao, D., Powolny, A. A., & Singh, S. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802529200 · Cited by 170
The role of mTOR in the management of solid tumors: An overview
Strimpakos, A. S., Karapanagiotou, E. M., Saif, M. W., & Syrigos, K. N. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.006 · Cited by 160
Cytotoxic and Antioxidative Sesquiterpenoids from Heterotheca inuloides
Kubo, I., Chaudhuri, S. K., Kubo, Y., Sanchez, Y., Ogura, T., Saito, T., Ishikawa, H., & Haraguchi, H. (1996) · Planta Medica · doi:10.1055/s-2006-957932 · Cited by 154
Brolin, J., Ekman, P., & Skoog, L. K. (1992) · The Prostate · doi:10.1002/pros.2990200404 · Cited by 150
Assefa, Z., Vantieghem, A., Garmyn, M., Declercq, W., Vandenabeele, P., Vandenheede, J. R., Bouillon, R., Merlevede, W. J., & Agostinis, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002634200 · Cited by 148
Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
McAuliffe, P. F., Meric‐Bernstam, F., Mills, G. B., & Gonzalez-Angulo, A. M. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.s.013 · Cited by 146
Yang, L., Xie, S., Jamaluddin, M. S., Altuwaijri, S., Ni, J., Kim, E., Chen, Y.-T., Hu, Y.-C., Wang, L., Chuang, K.-H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504461200 · Cited by 131
Lebedeva, I. V., Sarkar, D., Su, Z.-Z., Kitada, S., Dent, P., Stein, C. A., Reed, J. C., & Fisher, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206891 · Cited by 130
Nuclear Factor-Kappa B: From Clone to Clinic
Ahn, K., Sethi, G., & Aggarwal, B. B. (2007) · Current Molecular Medicine · doi:10.2174/156652407782564363 · Cited by 122
Self-citationKumar, A., Malik, F. A., Bhushan, S., Sethi, V. K., Shahi, A. K., Kaur, J., Taneja, S. C., Qazi, G. N., & Singh, J. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.10.003 · Cited by 113
Hur, J., Hyun, M., Lim, S., Lee, W., & Kim, D. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22198 · Cited by 107
Campone, M., Lévy, V., Bourbouloux, E., Rigaud, D. B., Bootle, D., Dutreix, C., Zoellner, U., Shand, N., Calvo, F. M., & Raymond, É. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604851 · Cited by 97
Anti-Platelet Aggregation and Chemical Constituents from the Rhizome ofGynura japonica
Lin, W., Kuo, Y., Chang, Y., Teng, C., Wang, E., Ishikawa, T., & Chen, I. (2003) · Planta Medica · doi:10.1055/s-2003-42796 · Cited by 69
Choi, S., Hwang, J., Park, S., et al. (2008) · Phytotherapy Research · doi:10.1002/ptr.2419 · Cited by 50
Shimizu, M., SHOGAWA, H., Matsuzawa, T., et al. (1990) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.38.2283 · Cited by 47
Superoxide Anions Are Involved in Doxorubicin‐Induced ERK Activation in Hepatocyte Cultures
Navarro, R., Busnadiego, I., Ruiz‐Larrea, M. B., & Ruiz-Sanz, J. I. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.045 · Cited by 47
Chen, K., Peng, C.-C., Chiu, W., Cheng, Y., Huang, G.-T., Hsieh, C.-L., & Peng, R. Y. (2010) · Nutrition and Cancer · doi:10.1080/01635580903407130 · Cited by 42
Bartlett, J. M. S. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.s.017 · Cited by 28
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
Self-citationEssential oils: From extraction to encapsulation
Asbahani, A. E., Miladi, K., Badri, W., Sala, M., Addi, E. H. A., Casabianca, H., Mousadik, A. E., Hartmann, D., Jilale, A., Renaud, F. N. R., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.069 · Cited by 1,065
Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems
Sharifi-Rad, J., Sureda, A., Tenore, G., Daglia, M., Sharifi-Rad, M., Valussi, M., Tundis, R., Sharifi-Rad, M., Loizzo, M., Ademiluyi, A., et al. (2017) · Molecules · doi:10.3390/molecules22010070 · Cited by 889
Dahham, S., Tabana, Y., Iqbal, M., Ahamed, M., Ezzat, M., Majid, A., & Majid, A. (2015) · Molecules · doi:10.3390/molecules200711808 · Cited by 834
β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties
Fidyt, K., Fiedorowicz, A., Strządała, L., & Szumny, A. (2016) · Cancer Medicine · doi:10.1002/cam4.816 · Cited by 674
Metadata
- Authors
- Park, K.-R., Nam, D., Yun, H.-M., Lee, S.-G., Jang, H.-J., Sethi, G., Cho, S. K., & Ahn, K. S.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 312
- Issue
- 2
- Pages
- 178-188
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2044638102
- Cited by
- 331
- References
- 45
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.